Addus HomeCare, which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, posted revenues of $131.24 million for the quarter ended June 2018, surpassing the Zacks Consensus Estimate by 2.68%. This compares to year-ago revenues of $103.56 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Addus HomeCare shares have added about 98.4% since the beginning of the year versus the S&P 500's gain of 6.2%. What's Next for Addus HomeCare? While Addus HomeCare has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?